Xbrane Biopharma AB   Report issue

For profit Phase 3
Founded: Solna Sweden (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2019
NCT03805100
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Xbrane Biopharma AB